Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

NCT00393679 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4112

Enrollment

OTHER

Sponsor class

Conditions

Fever
Malaria

Interventions

DRUG: amodiaquine-artesunate (ASAQ)
DRUG: dihydroartemisinin-piperaquine (DHAPQ)
DRUG: artemether-lumefantrine (AL)
DRUG: Lapdap (Chlorproguanil-Dapsone) + artesunate (AS)

Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]